Unibest
← Back to patent-cliff list

CAS 1304512-41-1

(6S,9R,12R,15S,18R)-6-Acetamido-9-[[(acetamidomethyl)sulfanyl]methyl]-18-benzyl-N-[(2S)-1-hydrazinyl-1-oxo-5-[N'-(2,2,4,6,7-pentamethyl-2,3-dihydro-1-benzofuran-5-sulfonyl)carbamimidamido]pentan-2-yl]-15-[(1H-imidazol-4-yl)methyl]-1-imino-12-methyl-7,10,13,16-tetraoxo-1-[(2,2,4,6,7-pentamethyl-2,3-dihydro-1-benzofuran-5-sulfonyl)amino]-2,8,11,14,17-pentaazanonadecan-19-amide

Codes: (VI)443746-2-a

Application context (from source-drug indications)

下丘脑肥胖Setmelanotide Acetate巴德特-别德尔综合征Setmelanotide AcetateObesitySetmelanotide AcetatePrader-Willi综合征Setmelanotide Acetate垂体疾病Setmelanotide Acetate联合性垂体激素缺乏症Setmelanotide Acetate

Source drugs (routes using this intermediate)

DrugTierExpiry
Setmelanotide AcetateTier C — Watch / trade-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

Intermediates available on this site

No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.